Patents-Review.com
🔗 Permalink
Assignee profile:

TRANSGENE S.A.

City:

STRASBOURG CEDEX

Country:

France

Published Applications:

12

Last publication date:

2010-08-05

Patent Grants:

6

Last grant date:

2011-05-24

Top Inventors for applications by TRANSGENE S.A.

These are the the leading inventors for applications assigned to TRANSGENE S.A.:

Recent patent applications by TRANSGENE S.A.

TRANSGENE S.A. based in STRASBOURG CEDEX, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2010-08-05 ✅ Patent 7,947,288 granted on 2011-05-24
US20100196324A1
Chemistry; metallurgy

Viral particles encoding multifunctional cytokines

 #2 | 2010-03-25
US20100074869A1
Chemistry; metallurgy

Multifunctional Cytokines

 #3 | 2010-03-11
US20100061957A1
Chemistry; metallurgy

HPV-16-BASED PAPILLOMAVIRUS VACCINES

 #4 | 2010-03-04
US20100055069A1
Chemistry; metallurgy

HPV-18-BASED PAPILLOMAVIRUS VACCINES

 #5 | 2009-12-24
US20090317422A1
Human necessities

USE OF PPD FOR THE ADJUVANTATION OF A NUCLEIC ACID VACCINE

 #6 | 2009-04-02 ✅ Patent 8,067,228 granted on 2011-11-29
US20090087449A1
Chemistry; metallurgy

Nucleic acid compositions and their use against the hepatitic C virus

 #7 | 2009-03-19 ✅ Patent 8,080,525 granted on 2011-12-20
US20090075879A1
Chemistry; metallurgy

Peptide compositions and their use against the hepatitis C virus

 #8 | 2007-01-25 ✅ Patent 7,393,831 granted on 2008-07-01
US20070020285A1
Chemistry; metallurgy

Peptide compositions and their use against HCV

 #9 | 2006-07-27 ✅ Patent 7,378,265 granted on 2008-05-27
US20060166345A1
Chemistry; metallurgy

Method of inactivating enveloped viruses in a viral preparation of non-enveloped viruses

 #10 | 2005-11-01 ✅ Patent 6,960,469 granted on 2005-11-01
US9927933
-

Adenoviral vectors encoding an antibody fused to a CD4 extracellular domain

 #11 | 2005-06-30
US20050142640A1
Chemistry; metallurgy

MUC-1 derived peptides

 #12 | 2005-05-26
US20050112187A1
Human necessities

Combination product intended for carrying out a cytotoxic treatment, in particular an antitumour treatment, in a mammal
AssigneeID:

218336 ⎘